IRadimed announces 2 updates to board of directors

IRadimed Corporation, a Winter Springs, Fla.-based developer and manufacturer of MRI-related products, announced this week that Anthony Vuoto was appointed to the company’s board of directors. Also, Jim Hawkins, chairman of the board, will not stand for re-election.

Vuoto recently retired from his position as general manager of retail payment solutions at US Bank and has held numerous leadership positions at financial institutions throughout his career.

“I am pleased to welcome Tony to the Board of Directors,” Roger Susi, IRadimed president and CEO, said in a prepared statement. “Tony is an experienced leader with deep knowledge in a number of strategic and organizational areas. We look forward to working closely with him and benefiting from his varied experiences.”

Vuoto will also serve as a member of IRadimed’s audit committee and chairman of the compensation committee.

Hawkins has been chairman of the board since 2013, and a member of the board of directors since 2005. He will stay at the position until the company’s 2016 annual meeting of stockholders, where Susi will be nominated to replace him.

“Jim has provided valuable insight and leadership to me and the management team during his tenure as Chairman and prior to that as a member of the board these past 12 years,” Susi said in the same statement.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.